28.89

4.16% 1.155

After Hours: 28.87 -0.025 -0.09%

Assembly Biosciences Inc (ASMB)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Assembly Biosciences Inc stock is traded at $28.89, with a volume of 179.40K. It is up +4.16% in the last 24 hours and up +26.18% over the past month. Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Previous Close:

$27.74

Open:

$27.74

24h Volume:

179.40K

Relative Volume:

0.96

Market Cap:

$572.62M

Revenue:

$71.10M

Net Income/Loss:

$-6.38M

P/E Ratio:

-24.06

EPS:

-1.2009

Net Cash Flow:

$-39.84M

1W Performance:

+7.18%

1M Performance:

+26.18%

6M Performance:

-5.51%

1Y Performance:

+59.29%

1-Day Range:

$27.20

$29.00

1-Week Range:

$26.06

$29.00

52-Week Range:

$16.90

$39.70

Assembly Biosciences Inc Stock (ASMB) Company Profile

Name

Assembly Biosciences Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

(833) 409-4583

Address

TWO TOWER PLACE, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

ASMB's Discussions on Twitter

Compare ASMB vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ASMB Assembly Biosciences Inc	28.89	544.58M	71.10M	-6.38M	-39.84M	-1.2009
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-24-25	Initiated	Citizens JMP	Mkt Outperform
Aug-18-25	Resumed	H.C. Wainwright	Buy
Mar-25-25	Initiated	Guggenheim	Buy
Sep-20-24	Upgrade	Jefferies	Hold → Buy
Sep-13-21	Initiated	H.C. Wainwright	Neutral
Sep-02-21	Downgrade	William Blair	Outperform → Mkt Perform
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-06-20	Downgrade	Jefferies	Buy → Hold
Oct-19-20	Initiated	Truist	Buy
Oct-16-19	Initiated	Mizuho	Buy
Nov-19-18	Initiated	Leerink Partners	Outperform
Oct-08-18	Upgrade	B. Riley FBR	Neutral → Buy
Aug-08-18	Initiated	Robert W. Baird	Outperform
Apr-13-18	Downgrade	Chardan Capital Markets	Buy → Neutral
Jan-05-18	Initiated	B. Riley FBR, Inc.	Neutral
Nov-08-17	Initiated	Jefferies	Buy
May-30-17	Initiated	Chardan Capital Markets	Buy

View All

Assembly Biosciences Inc Stock (ASMB) Latest News

Jun 30, 2026

Discipline and Rules-Based Execution in ASMB Response - Stock Traders Daily

Jun 30, 2026

Jun 29, 2026

Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Index - marketscreener.com

Jun 29, 2026

Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Index - marketscreener.com

Jun 29, 2026

Assembly Biosciences, Inc.(NasdaqGS:ASMB) dropped from Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 26, 2026

Health Care had the best week vs. the S&P 500 on record (XLV:NYSEARCA) - Seeking Alpha

Jun 26, 2026